Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to Tuesday, 5 December – a date on the calendar that has become a staple for fans of the great [more…]
Closing Bell: ASX wins friends and influences portfolios after Monday outperformance
The ASX benchmark has monstered Monday 9 of 11 sectors in the green Small caps led by Compumedics Australia’s share market put in a powerful [more…]
In Case You Missed It: Home sleep test nabs FDA approval
Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing [more…]
First Lithium turns up proof the Russians were right: There’s lithium at Gouna!
Gouna’s lithium was discovered by Russian geologists in the 1960s Current project owner First Lithium in the midst of a 8,000m drilling program Three cut [more…]
ASX Large Caps: Shares rally as gold hits all-time high, Bitcoin above US$40k for first time this year
ASX rallied almost 1pc on Monday Rates sensitive stocks including Tech and Real Estate led the rally Gold hits all-time high, as Bitcoin surges above [more…]
ADX Energy extends collaboration with MND through farm-out of gas exploration prospects in Upper Austria
ADX Energy farms out 50% stake in investment area within ADX-AT-I licence to MND Austria MND to pay ADX €450,000 in back costs and provide [more…]
Hillgrove Resources a step closer to first revenues as copper concentrate containers arrive at Port Adelaide
410 ‘rotainers’ have arrived at Port Adelaide in preparation to transport copper concentrate from Hillgrove’s Kanmantoo project The first containers of concentrate will be collected [more…]
ASX Small Caps Lunch Wrap: Who’s lack of due diligence has cost them their job this week?
Local markets are smashing it this morning, with the ASX 200 benchmark up 1.15% by midday and the goldies extending their gains from last week [more…]
Neurotech to extend Phase 2/3 autism spectrum disorder trial to adults
Neurotech receives HREC approval to extend Phase II/III ASD trial to adults Company committed to developing NTI164 as a first-line treatment for patients with autism [more…]
Ground Breakers: Is rare earths developer Arafura about to buck history?
Nolans project price tag of $1.68bn will be funded by a 50-50 mix of debt and equity Arafura inks in-principle support from Export-Import Bank of [more…]
